Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal
Status:
Completed
Trial end date:
2019-07-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 or
placebo when dosed for 5 days in adults with tobacco use disorder who voluntarily abstain
from the use of cigarettes.